These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10813531)

  • 1. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy.
    Cao H; Vergé V; Baron C; Martinache C; Leon A; Scholl S; Gorin NC; Salamero J; Assari S; Bernard J; Lopez M
    J Hematother Stem Cell Res; 2000 Apr; 9(2):183-94. PubMed ID: 10813531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro production of dendritic cells from human blood monocytes for therapeutic use.
    Garderet L; Cao H; Salamero J; Vergé V; Tisserand E; Scholl S; Gorin NC; Lopez M
    J Hematother Stem Cell Res; 2001 Aug; 10(4):553-67. PubMed ID: 11522238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
    Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
    J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
    Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
    J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell culture: a simple closed culture system using ficoll, monocytes, and a table-top centrifuge.
    Celluzzi CM; Welbon C
    J Hematother Stem Cell Res; 2003 Oct; 12(5):575-85. PubMed ID: 14594514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serotonin on the differentiation of human monocytes into dendritic cells.
    Katoh N; Soga F; Nara T; Tamagawa-Mineoka R; Nin M; Kotani H; Masuda K; Kishimoto S
    Clin Exp Immunol; 2006 Nov; 146(2):354-61. PubMed ID: 17034589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
    Lan CY; Liu JH; Xia JC; Zheng LM
    Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
    Menetrier-Caux C; Thomachot MC; Alberti L; Montmain G; Blay JY
    Cancer Res; 2001 Apr; 61(7):3096-104. PubMed ID: 11306493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of suppressive phenotype in monocyte-derived dendritic cells by leukemic cell products and IL-1β.
    Motta JM; Sperandio A; Castelo-Branco MT; Rumjanek VM
    Hum Immunol; 2014 Jul; 75(7):641-9. PubMed ID: 24768898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of unpulsed dendritic cells derived from granulocyte/macrophage colony-stimulating factor-mobilized peripheral blood CD34+ cells and monocytes in patients with advanced carcinoma.
    Triozzi PL; Kim J; Aldrich W
    J Hematother Stem Cell Res; 2003 Jun; 12(3):279-87. PubMed ID: 12857369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy.
    Wong EC; Maher VE; Hines K; Lee J; Carter CS; Goletz T; Kopp W; Mackall CL; Berzofsky J; Read EJ
    Cytotherapy; 2001; 3(1):19-29. PubMed ID: 12028840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
    Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
    J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.